Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient
نویسندگان
چکیده
منابع مشابه
Alemtuzumab versus antithymocyte globulin induction therapies in kidney transplantation patients
Alemtuzumab (ALEM) is widely used as an induction therapy for organ transplantation, and numerous randomized controlled trials (RCTs) have been published to evaluate its efficacy and safety in kidney transplantation as compared with antithymocyte globulin (ATG). The purpose of this study was to compare the benefits and safety of ALEM with those of ATG for induction therapy.A systematic literatu...
متن کاملPrevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation.
BACKGROUND Despite their well-known side-effects, corticosteroids (Cs) are currently used after kidney transplantation. Avoidance of Cs may improve patient quality of life and eventual long-term survival. We report on a regimen using antithymocyte globulin (ATG) and mycophenolate mofetil (MMF) for induction, and cyclosporin (CsA) plus MMF for maintenance treatment of recipients of primary kidne...
متن کاملTailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation
Background Rabbit antithymocyte globulin (rATG) is the most widely used kidney transplant induction immunotherapy in the United States. It was recently Food and Drug Administration approved for this indication with typical dose recommendations of 1.5 mg/kg for up to 7 days given via a central line. Methods We theorized that reduced rATG dosing when compared with conventional dosing (6-10.5 mg...
متن کاملComparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.
Refractory cytopenia of childhood is the most common subtype of myelodysplastic syndrome in children. In this study, we compared the outcome of immunosuppressive therapy using horse antithymocyte globulin (n=46) with that using rabbit antithymocyte globulin (n=49) in 95 patients with refractory cytopenia of childhood and hypocellular bone marrow. The response rate at 6 months was 74% for horse ...
متن کاملA Multicenter Trial of Antithymocyte Globulin in
One hundred fifty patients with bone marrow failure were treated in three groups with antithymocyte globulin (ATG; Upjohn. Kalamazoo, Ml) in a multicenter trial. Patients were assessed at 3, 6, and 1 2 months after initiation of treatment by three criteria: transfusion independence. clinical improvement, and blood counts. Group I consisted of 77 patients with acute severe aplastic anemia. rando...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Anaesthesiology Clinical Pharmacology
سال: 2017
ISSN: 0970-9185
DOI: 10.4103/joacp.joacp_128_16